Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma

BMJ Support Palliat Care. 2013 Mar;3(1):4-5. doi: 10.1136/bmjspcare-2012-000348. Epub 2012 Oct 25.

Authors

Helen Farrell¹, Peter Eastman

Affiliation

¹ Palliative Care, Barwon Health, Geelong, Australia.

PMID: 24644317
DOI: 10.1136/bmjspcare-2012-000348

No abstract available

Keywords: Clinical decisions; Haematological disease; Pharmacology.

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antipsychotic Agents / adverse effects*
Antipsychotic Agents / therapeutic use
Delirium / complications
Delirium / drug therapy*
Humans
Lymphoma, Large B-Cell, Diffuse / complications*
Male
Neutropenia / chemically induced*
Palliative Care / methods*
Risperidone / adverse effects*
Risperidone / therapeutic use

Substances

Antipsychotic Agents
Risperidone